Hiroshi Isobe

机构：The Open University of Japan, Kumamoto University · ORCID：0000-0002-5711-4629

发表论文 400 篇 · 总被引 11445 次 · h-index 39

代表论文

• Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study (2018 · PLoS ONE · 被引 95)
• Cerium oxide (CeO2-x) nanoparticles with high Ce3+ proportion synthesized by pulsed plasma in liquid (2020 · Ceramics International · 被引 67)
• Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702) (2019 · The Oncologist · 被引 66)
• A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302) (2019 · Lung Cancer · 被引 48)
• Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations (2018 · ESMO Open · 被引 42)
• A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial (2018 · Annals of Oncology · 被引 33)